{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:06:01Z","timestamp":1782255961967,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Shandong Medical and Health Technology Development Project","award":["2017WS520"],"award-info":[{"award-number":["2017WS520"]}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.amjms.2019.09.009","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T11:11:07Z","timestamp":1569928267000},"page":"400-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection"],"prefix":"10.1016","volume":"358","author":[{"given":"Qi","family":"Congcong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Hengting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shuhui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2019.09.009_bib0001","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/0970-2113.201305","article-title":"Diagnosis and management options in malignant pleural effusions","volume":"34","author":"Dixit","year":"2017","journal-title":"Lung India"},{"key":"10.1016\/j.amjms.2019.09.009_bib0002","doi-asserted-by":"crossref","first-page":"39355","DOI":"10.1038\/srep39355","article-title":"Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion","volume":"6","author":"Biaoxue","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2019.09.009_bib0003","first-page":"839","article-title":"Management of Malignant Pleural Effusions","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"An Off ATS\/STS\/STR Clin Pract Guidel"},{"key":"10.1016\/j.amjms.2019.09.009_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/CMAR.S95663","article-title":"Management of malignant pleural effusion: challenges and solutions","volume":"9","author":"Penz","year":"2017","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.amjms.2019.09.009_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12957-015-0729-9","article-title":"Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions","volume":"13","author":"Biaoxue","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.amjms.2019.09.009_bib0006","first-page":"14701","article-title":"Matrine promotes the efficacy and safety of platinum-based doublet chemotherapy for advanced non-small cell lung cancer","volume":"8","author":"Rong","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0007","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/jcmm.12570","article-title":"Lentinan exerts synergistic apoptotic effects with paclitaxel in A549 cells via activating ROS-TXNIP-NLRP3 inflammasome","volume":"19","author":"Liu","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0008","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejca.2016.06.012","article-title":"Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701)","volume":"65","author":"Yoshino","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjms.2019.09.009_bib0009","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpba.2013.02.012","article-title":"Quality evaluation of lentinan injection produced in China","volume":"78-79","author":"Chen","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.amjms.2019.09.009_bib0010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2174\/1871520611313050002","article-title":"The use of lentinan for treating gastric cancer","volume":"13","author":"Ina","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.amjms.2019.09.009_bib0011","first-page":"2739","article-title":"Individual patient based meta-analysis of lentinan for unresectable\/recurrent gastric cancer","volume":"29","author":"Oba","year":"2009","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"10.1016\/j.amjms.2019.09.009_bib0012","first-page":"e29","article-title":"A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer","volume":"52","author":"Yin","year":"2015","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.amjms.2019.09.009_bib0013","first-page":"1062","article-title":"Clinical observation of thermotherapy combined with thoracic injection of lentinan in treatment of cancerous hydrothorax of patients with lung cancer","volume":"31","author":"Li","year":"2011","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.amjms.2019.09.009_bib0014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.36076\/ppj.2009\/12\/35","article-title":"Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 3: systematic reviews and meta-analyses of randomized trials","volume":"12","author":"Manchikanti","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.amjms.2019.09.009_bib0015","doi-asserted-by":"crossref","first-page":"86902","DOI":"10.18632\/oncotarget.13509","article-title":"Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies","volume":"7","author":"Biaoxue","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.amjms.2019.09.009_bib0016","first-page":"213","article-title":"Treatment of elderly malignant pleural effusion by intravenous injection of lentinan (in Chinese)","volume":"10","author":"Yingman","year":"2008","journal-title":"J North China Coal Med Coll"},{"key":"10.1016\/j.amjms.2019.09.009_bib0017","first-page":"288","article-title":"Clinical observation of cisplatin combined with lentinan in the treatment of malignant pleural effusion (in Chinese)","volume":"15","author":"Yongmei","year":"2008","journal-title":"Chinese J Clin Oncol Rehabil"},{"key":"10.1016\/j.amjms.2019.09.009_bib0018","first-page":"636","article-title":"Lentinan combined with cisplatin in the treatment of malignant pleural effusion (in Chinese)","volume":"14","author":"Yong","year":"2008","journal-title":"Hebei Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0019","first-page":"177","article-title":"Efficacy of lentinan combined with cisplatin in the treatment of malignant pleural effusion (in Chinese)","volume":"35","author":"Xiaoyu","year":"2009","journal-title":"J Modern Clin Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0020","first-page":"18","article-title":"Treatment of malignant pleural effusion by minitraumatic tube installation with intrapleural injection cisplatin and lentinan (in Chinese)","volume":"15","author":"Xin","year":"2009","journal-title":"Surg J Chinese Integr Traditional Western Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0021","first-page":"1829","article-title":"Curative effect observation of cisplatin combined with lentinan on patients with malignant pleural effusions (in Chinese)","volume":"19","author":"Yan","year":"2010","journal-title":"Mod J Integr Traditional Chin Western Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0022","first-page":"13","article-title":"Treatment of malignant pleural effusion with intrapleural injection lentinan and cisplatin (in Chinese)","volume":"12","author":"Sujuan","year":"2010","journal-title":"J Xiangnan Univer (Med Sci)"},{"key":"10.1016\/j.amjms.2019.09.009_bib0023","first-page":"3461","article-title":"Clinical observation of cisplatin combined with lentinan in the treatment of malignant pleural effusion (in Chinese)","volume":"19","author":"Zengbai","year":"2010","journal-title":"Mod J Integr Traditional Chin Western Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0024","first-page":"225","article-title":"The clinical effect of cisplatin and lentinan intrathoracic injection in senile pafients with malignant pleural effusion (in Chinese)","volume":"16","author":"Chunwei","year":"2011","journal-title":"J Clin Pulmon Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0025","first-page":"1036","article-title":"Clinical analysis of central venous catheter drainage combined with lentinan plus cisplatin in the treatment of malignant pleural effusion (in Chinese)","volume":"17","author":"Gang","year":"2011","journal-title":"Hebei Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0026","first-page":"761","article-title":"Clinical study of lentinan injection combined with cisplatin perfusion in the treatment of malignant pleural effusion (in Chinese)","volume":"33","author":"Junli","year":"2012","journal-title":"Jilin Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0027","first-page":"840","article-title":"Treatment of malignant pleural effusion caused by lung cancer via intrapleural injection of cisplatin and lentinan (in Chinese)","volume":"44","author":"Xianghui","year":"2013","journal-title":"New Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0028","first-page":"2086","article-title":"Cisplatin combined with lentinan intrathoracic injection of elderly lung cancer with pleural effusion efficacy analysis (in Chinese)","volume":"18","author":"Fu","year":"2013","journal-title":"J Clin Pulm Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0029","first-page":"30","article-title":"Clinical study of lentinan combined with cisplatin in the treatment of lung cancer pleural effusion (in Chinese)","volume":"33","author":"Daoming","year":"2014","journal-title":"J Anhui Univ Chin Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0030","first-page":"40","article-title":"Clinical observation of intrapleural injection of cisplatin combined with lentinan in the treatment of lung cancer patients with malignant pleural effusion (in Chinese)","volume":"32","author":"Hongyan","year":"2016","journal-title":"Chin Community Dr"},{"key":"10.1016\/j.amjms.2019.09.009_bib0031","first-page":"94","article-title":"Clinical effect of letinous edodes polysaccharide combined with chemotherapeutics in the treatment of malignant pleural effusion (in Chinese)","volume":"12","author":"Yingming","year":"2017","journal-title":"China Prac Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0032","first-page":"135","article-title":"Efficacy analysis and clinical study on the treatment of pleural effusion of lung cancer using cisplatin combined with lentinan (in Chinese)","volume":"15","author":"Ling","year":"2017","journal-title":"Guide China Med"},{"key":"10.1016\/j.amjms.2019.09.009_bib0033","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.3892\/or.2013.2349","article-title":"Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancermediated malignant pleural effusion","volume":"29","author":"Du","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.amjms.2019.09.009_bib0034","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1567-5769(01)00212-0","article-title":"The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content","volume":"2","author":"Murata","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.amjms.2019.09.009_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01754412","article-title":"Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells Cancer","volume":"36","author":"Ladanyi","year":"1993","journal-title":"Immunol Immunother"},{"key":"10.1016\/j.amjms.2019.09.009_bib0036","first-page":"60","article-title":"[Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism]","volume":"27","author":"Wang","year":"2007","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.amjms.2019.09.009_bib0037","first-page":"1773","article-title":"Augmentation of lymphokine-activated killer cell activity by lentinan","volume":"13","author":"Tani","year":"1993","journal-title":"Anticancer Res"},{"key":"10.1016\/j.amjms.2019.09.009_bib0038","first-page":"37","article-title":"Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan","volume":"76","author":"Herlyn","year":"1985","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.amjms.2019.09.009_bib0039","first-page":"87","article-title":"Effects of lentinan on VEGF expression and MVD in Lewis lung carcinoma mice (in Chinese)","volume":"30","author":"Peng","year":"2008","journal-title":"J Yichun Coll"},{"key":"10.1016\/j.amjms.2019.09.009_bib0040","first-page":"173","article-title":"The application of lentinan combined with cisplatin in the treatment of malignant pleural effusion","volume":"14","author":"Zhengfei","year":"2009","journal-title":"Chinese Clin Oncol"},{"key":"10.1016\/j.amjms.2019.09.009_bib0041","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/s12885-016-2935-4","article-title":"Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis","volume":"16","author":"Biaoxue","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.amjms.2019.09.009_bib0042","first-page":"2365","article-title":"The effect of lentinan combination therapy for unresectable advanced gastric cancer","volume":"32","author":"Higashi","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.amjms.2019.09.009_bib0043","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s13277-013-0680-8","article-title":"Effect of lentinan combined with docetaxel and cisplatin on the proliferation and apoptosis of BGC823 cells","volume":"34","author":"Zhao","year":"2013","journal-title":"Tumour Biol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962919303477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962919303477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:14:58Z","timestamp":1762082098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962919303477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0002962919303477"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2019.09.009","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Efficacy and Safety for Lentinan in the Control of the Malignant Pleural Effusions via Intrapleural Injection","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2019.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}